Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
62.1M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
6.9M
-
Shares change
-
+6.9M
-
Total reported value, excl. options
-
$145M
-
Value change
-
+$145M
-
Number of buys
-
34
-
Price
-
$21.13
Significant Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q3 2016
34 filings reported holding PTGX - Protagonist Therapeutics, Inc - Common Stock as of Q3 2016.
Protagonist Therapeutics, Inc - Common Stock (PTGX) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.9M shares
of 62.1M outstanding shares and own 11.11% of the company stock.
Largest 10 shareholders include FMR LLC (2.13M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.58M shares), Cormorant Asset Management, LLC (800K shares), RA CAPITAL MANAGEMENT, LLC (754K shares), BVF INC/IL (375K shares), Foresite Capital Management III, LLC (346K shares), BlackRock Fund Advisors (206K shares), VANGUARD GROUP INC (142K shares), DAFNA Capital Management LLC (124K shares), and GEODE CAPITAL MANAGEMENT, LLC (92.8K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.